Insulet reported Q3 revenue of $842 million, up 19.2% and above guidance. Adjusted EPS rose 59.9% to $1.99. The company raised its FY2026 total revenue growth outlook to 21%-22% constant currency and lifted adjusted operating margin expansion guidance to 150 bps. The board authorized a $1 billion share repurchase program, with $400 million expected in Q4.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
